Cargando…
Redirecting the focus of cancer immunotherapy to premalignant conditions
Much progress has been made in introducing immunological treatment approaches for cancer, with lessons learned from both the successes and failures of immunotherapy. Among the challenges of immunotherapeutic approaches for cancer are the multitudes of mechanisms by which cancers are known to subvert...
Autor principal: | Young, M. Rita I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925415/ https://www.ncbi.nlm.nih.gov/pubmed/28130162 http://dx.doi.org/10.1016/j.canlet.2017.01.022 |
Ejemplares similares
-
Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer
por: Garcia-Mouronte, Emilio, et al.
Publicado: (2023) -
Premalignant Conditions of Bone
por: Eckhoff, Michael D., et al.
Publicado: (2022) -
Premalignant conditions of bone
por: Horvai, Andrew, et al.
Publicado: (2006) -
Novel Redirected T–Cell Immunotherapies for Advanced Prostate Cancer
por: Dorff, Tanya B., et al.
Publicado: (2022) -
The Epidemiology of Skin Cancer in Queensland: The Significance of Premalignant Conditions
por: Carmichael, G. G.
Publicado: (1961)